MoneyWorks4Me

Marksans Pharma - Quaterly Results

13 Aug 2024 Evaluate
The sales moved up 39.82% to Rs. 2545.27 millions for the June 2024 quarter as compared to Rs. 1820.41 millions during the year-ago period.Net profit declined -27.55% to Rs. 320.15 millions from Rs. 441.91 millions.Operating profit for the quarter ended June 2024 decreased to 494.18 millions as compared to 593.81 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 2545.27 1820.41 39.82 2545.27 1820.41 39.82 8532.73 6552.04 30.23
Other Income 81.52 326.23 -75.01 81.52 326.23 -75.01 620.73 604.82 2.63
PBIDT 494.18 593.81 -16.78 494.18 593.81 -16.78 2020.08 1523.85 32.56
Interest 2.83 2.62 8.02 2.83 2.62 8.02 9.88 36.13 -72.65
PBDT 491.35 591.19 -16.89 491.35 591.19 -16.89 2010.20 1487.72 35.12
Depreciation 68.36 47.24 44.71 68.36 47.24 44.71 291.28 167.37 74.03
PBT 422.99 543.95 -22.24 422.99 543.95 -22.24 1718.92 1320.35 30.19
TAX 102.84 102.04 0.78 102.84 102.04 0.78 381.34 291.69 30.73
Deferred Tax -0.74 26.94 -102.75 -0.74 26.94 -102.75 6.78 -1.71 -496.49
PAT 320.15 441.91 -27.55 320.15 441.91 -27.55 1337.58 1028.66 30.03
Equity 453.16 453.16 0.00 453.16 453.16 0.00 453.16 45316.00 -99.00
PBIDTM(%) 19.42 32.62 -40.48 19.42 32.62 -40.48 23.67 23.26 1.79
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..